The role of high fat diets in breast cancer/mammary tumor (MT) development is controversial. This may be partially attributable to variable effects of high fat diets on body weight. Here, we used a moderately high fat diet (32.5% fat calories) expected to cause obesity in most mice, but predicted to result in some mice remaining in the weight range of mice fed the low fat diet (11% fat calories). This provided the opportunity to compare mice fed the high fat diet exhibiting different body weights and mice of similar weight consuming high vs low fat diets. EXPERIMENTAL METHODS: Transgenic MMTV-TGF-a mice, a model of postmenopausal breast cancer, consumed a low fat diet, that is, chow-fed (n ¼ 25) or a moderately high fat diet from 10 weeks of age (n ¼ 51). Body weight at 34 weeks of age was used to assign high fat diet mice to obesity-prone4overweight4obesity-resistant groups (n ¼ 17) (Po0.0001). Mice were euthanized when MTs developed or at 85 weeks of age. RESULTS: Final body weights were highest in obesity-prone4overweight 4obesity-resistant ¼ chow-fed mice. Fat pads and fat pad:carcass were heaviest in obesity-prone followed by overweight mice. However, obesity-resistant mice had fat pad weights and fat pad:carcass three-fold greater than chow-fed mice. All groups had MT incidences between 72 and 82%. Obesity-prone mice exhibited the shortest MT latency (Po0.0001), but obesity-resistant mice had significantly shorter latency than chow-fed mice. CONCLUSIONS: Consumption of a high fat diet increased adiposity and shortened MT latency in relation to its effect on body weight. These results indicate a complex role of dietary fat level on mammary tumorigenesis.
Introduction
The role of dietary fat intake in the development and progression of human breast cancer is an unresolved issue. While breast cancer incidence has been positively correlated with per capita fat intake, 1 the results of related epidemiological investigations arrive at varied conclusions based on study design. For example, the combined analysis of 12 casecontrol studies indicates a higher risk for breast cancer associated with increased fat intake. 2 Conversely, a pooled analysis of cohort studies reveals no association of dietary fat intake with the risk of developing breast cancer. 3 In agreement, results of long-term follow-up of a large cohort of women in the Nurses' Health Study found no association between dietary fat intake and subsequent breast cancer risk. 4 However, another prospective study indicated an increased risk for postmenopausal breast cancer in association with increased dietary fat intake, although no specific type of fat was identified to be a factor. 5 Explanations owing to the lack of positive findings in most cohort studies or aimed at discrediting the positive findings in case-control studies have been put forth. [6] [7] [8] [9] Others have suggested that the level of dietary fat intake may be an important determinant of breast cancer risk only in populations, with a low fat diet intake. 10 At present, the end result is that no definitive conclusions can be made either supporting or denying a role for elevated dietary fat in the development of human breast cancer.
Rodent models have also been used to examine the effect of low vs high dietary fat intake on the development of mammary tumors (MTs), and high fat diets have been reported to affect tumor latency or incidence in rats and mice with chemically induced, spontaneous, or transplanted MTs as reviewed in Welsch. 11 Frequently, however, comparisons were made to animals with very low fat intakes limited in overall fat intake, linoleic acid and/or total caloric intakes. However, it is well established that caloric restriction prevents MT development in rodents. [12] [13] [14] [15] [16] [17] Thus, rather than concluding that dietary fat promotes MT development, an alternative interpretation could be that there is a protective effect against MT formation in these calorie-deprived animals.
To address interactions between body weight and dietary fat intake on subsequent MT development, we have taken a novel approach by feeding mice a high fat diet such that we could distinguish those that gained weight and became obese (ie obesity prone) from those that remain in the weight range of those fed with a low fat diet (ie obesity resistant). This experimental design is based on earlier reports on a variety of high fat diets fed to Sprague-Dawley and Wistar rats, and on a recent study using male C57BL6 mice, which was published after the present study was underway. [18] [19] [20] [21] [22] We hypothesized that this dietary intervention would allow us to assess MT development on body weight independent of dietary composition. In addition, the low fat fed group would provide the data for comparison of consumption of high fat vs low fat diets, independent of body weight. For our animal model, we chose murine mammary tumor virus (MMTV)-transforming growth factor (TGF)-a mice that develop MTs later in life and better reflect postmenopausal breast cancer than do carcinogen-induced and transplant models, where MT development occurs relatively early in life during periods of dynamic growth. Initially, an MT incidence of 30% at 15-16 months of age was reported for MMTV-TGFa mice. 23 When followed to 24 months of age MT incidence was increased to at least 50%. 24, 25 Here we describe the effect on body weight and MT development while feeding normally lean MMTV-TGF-a female mice a moderately high fat diet from 10 until 85 weeks of age.
Materials and methods
Female MMTV-TGF-a homozygous lean mice (C57BL6 background) were obtained from a colony maintained at the Hormel Institute. 24 Offspring remained with their mothers until 4 weeks of age. They were then housed with like-sexed pups, fed rodent chow and genotyped using DNA obtained from tail biopsies and procedures described previously. 24 From 6 weeks of age, mice were housed individually. At 10 weeks of age, 51 mice were switched to a diet consisting of a mixture of 48% chow, 44% condensed milk, 8% corn oil with a caloric density of 4.47 kcal/g and fat constituted 32.5% of the total caloric intake. 24 The diet was provided in pellet form (Research Diets, Inc., New Brunswick, NJ, USA). This diet was chosen because it was the original diet used to demonstrate these variable effects on body weight. 18 An additional 25 mice were maintained on Rodent Chow Diet #5001 (PMI Nutrition International, Inc., St. Louis, MO, USA), with a caloric density of 3.30 kcal/g, which contains 11% fat by calories from corn oil and were designated chow fed. Food was provided in stainless-steel holders attached to the sides of the cages. Food intakes and body weights were determined weekly at which time mice were palpated for the presence of MTs. Once MTs were detected, tumor growth was monitored using calipers. Mice were euthanized when MTs reached 20 mm in length or upon reaching 85 weeks of age. This age was chosen because of the high apparent MT incidence in mice assigned to the obesity-prone group. The animal room was maintained at 221C on a 12 h light:12 h dark cycle with a humidity level of 50%. The Hormel Institute Animal Facility is AAALAC accredited, and the University of Minnesota Animal Care and Use Committee approved this protocol.
There are no universally accepted criteria for categorizing obesity-prone and obesity-resistant rodents. [18] [19] [20] [21] [22] Some studies have used body weight gain during specified time periods and others used body weight attained. Also, animals with intermediate body weights/weight gain have been discarded from some experiments and from statistical analyses. In the present study, all high fat diet mice were used to determine if there was a graded effect of body weight on MT development. Body weight tertiles at 34 weeks of age were used to assign mice to either obesity-prone (body weight range of 29.6-53.2 g), overweight (body weight range of 25.4-29.4 g) or obesity-resistant (body weight range of 21.00-25.40 g) groups (n ¼ 17). This age was selected because at 34 weeks of age the average body weight of high fat diet mice was significantly greater than that of chow-fed mice (29.074.2 vs 25.771.2 g, Po0.0004,), and no MTs were detected by palpation in any mice. The body weight range for chow-fed mice was 23.9-29.3 g at 34 weeks of age. One mouse assigned to the overweight group was dropped from the final analyses because it was found dead and we were unable to perform a necropsy to assess MT status. When the mice were euthanized, organs (liver, kidneys, heart, spleen, ovaries, and lungs) were removed and weighed. MTs, other tumors, and any abnormal growth/ tissue were also removed and weighed. These tissues were processed as previously described. 26 Retroperitoneal and parametrial fat pads were removed and weighed and used as a surrogate for body fat, since we previously found similar results with either measurement (MP Cleary, unpublished). Data are presented as mean7s.d. MT incidence data were analyzed by w 2 and other comparisons among the experimental groups were made by analysis of variance (ANOVA) followed by Neuman-Keul's test to determine statistical differences between specific groups. Comparisons between high fat diet mice as a group and chow-fed mice were made by Student's t-test.
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Results
Age of death, body and fat pad weights Obesity-prone mice were significantly younger at death compared to all other groups followed by overweight mice (Table 1) . This was a consequence of earlier detection of putative palpable MTs in the two heaviest groups, necessitating euthanasia due to experimental design predicated on animal welfare. At 34 weeks of age, body weights of obesity-prone mice were significantly heavier than those of overweight and obesity-resistant mice and also of chow-fed mice (Table 1 ). In addition, overweight mice weighed significantly more than obesity-resistant mice, while body weights of chow-fed mice were intermediate between and not different from either overweight or obesity-resistant mice. Weight gain from 10 until 34 weeks of age followed a similar pattern (data not shown). Final body weights of obesity-prone mice remained significantly heavier compared to all other groups (Table 1) , and those of overweight mice were significantly heavier than those of obesity-resistant and chow-fed mice, which exhibited similar final body weights.
To determine whether the presence of MTs or other tumors affected final body weights, tumor and organ weights were subtracted and this was termed carcass weight. Carcass weight followed the same pattern as that described for final body weights with obesity-prone mice having the heaviest carcass, followed by overweight, and then obesity-resistant and chow-fed mice (data not shown).
Combined fat pad weights were heaviest in obesity-prone mice followed by overweight, obesity-resistant, and then chow-fed mice (Figure 1a) . Although fat pad weights of the obesity-resistant mice were three-fold heavier than those of chow-fed mice, these values were not significantly different using the Neuman-Keul's test after the ANOVA. However, when compared to Student's t-test, there was a significant difference. When fat pad weights were calculated relative to carcass weight, all values were significantly different from each other obesity-prone4overweight4obesity-resistant4chow-fed (Figure 1b) . Thus, despite having similar body weights, obesity-resistant mice, that consumed the high fat diet, had substantially more body fat as reflected by these adipose tissue weights than did chow-fed mice.
MT latency, incidence and burden
The average age of MT detection, whether identified by palpation or at necropsy, was significantly younger, 47.8 weeks, in obesity-prone mice compared to all other groups (Table 2) . MTs in overweight mice were detected at an intermediate age between the two other high fat diet groups, although the difference between overweight and obesityresistant groups did not reach statistical significance. Despite their similar body weights, obesity-resistant mice had a significantly earlier age of MT detection compared to chowfed mice.
Incidence rate for total MTs (ie those detected by palpation and at necropsy) ranged from 72 to 82% among the groups (Table 2 ). When the incidence rate for palpable MTs was calculated, obesity-prone mice still had an incidence rate of 76%, because all tumor-bearing mice were identified by the presence of palpable MTs. In contrast, only 36% of chow-fed mice had palpable MTs compared to a total MT incidence of 72%,that is, half of the tumor-bearing chow-fed mice had their MTs detected when they were euthanized at the termination of the experiment. Interestingly, the obesityresistant mice demonstrated a 64% higher incidence of palpable MTs compared to chow-fed mice with similar body weights. In addition, palpable MTs were detected at a younger age for obesity-resistant compared to chow-fed mice, although not statistically different with this number of mice. Numbers of MTs per tumor-bearing mouse were similar in all cases (Table 2 ). There was an overall significant effect of tumor weight, primarily attributable to higher tumor weight of overweight mice (Table 2) .
MT histopathology
For chow-fed mice, autopsies were available from 24/25 mice. All MTs from chow-fed mice were classified as lowgrade adenocarcinomas. Other pathology in chow-fed mice included a low-grade hepatocellular carcinoma in a tumorbearing mouse euthanized at 85 weeks of age, and a granulocytic sarcoma or leimyocarcinoma present in a nontumor-bearing mouse also euthanized at 85 weeks of age. Most chow-fed mice had either hepatic steatosis or vacuolated livers.
For mice fed with the high fat diet, histopathology results were available for 44/50 mice. The majority of MTs were also classified as low-grade adenocarcinomas, although two obesity-prone mice had high-grade adenocarcinomas. All obesity-prone mice were euthanized prior to 85 weeks of age due to suspected MTs, but in three of them no MTs were detected at necropsy, and in a fourth mouse the tumor was High fat diet and MT latency MP Cleary et al not malignant. No other malignancies were detected in high fat diet mice, although the majority of these mice also had either hepatic steatosis and/or vacuolated livers.
Caloric intake
From 10 until 34 weeks of age, cumulative caloric intakes were similar for obesity-prone (36247760) and chow-fed High fat diet and MT latency MP Cleary et al (36007363) mice, and were significantly greater than those of overweight (31087282) and obesity-resistant (29587642) mice (ANOVA, Po0.0002). Cumulative caloric intakes from 35 weeks of age until death were significantly lower for groups consuming the high fat diet compared to the caloric intake of chow-fed mice (data not shown). This is attributed to the fact that chow-fed mice lived longer than those consuming the high fat diet, that is, over 70% of chow-fed mice lived until 85 weeks of age compared to only 20% of high fat diet mice. When caloric intake for the latter part of the experiment (weeks 35 through 64 at least n ¼ 9/group) was calculated on a weekly basis, obesity-prone mice consumed slightly more calories on a weekly basis compared to the other groups (Figure 2 ). However, this was only a 4% increase relative to overweight and chow-fed mice, and 9% relative to obesity-resistant mice. Despite the lower caloric consumption of obesity-resistant mice, this did not prevent MT development. In contrast, moderate chronic caloric restriction using a low fat diet reduced MT incidence and extended tumor latency of MMTV-TGF-a mice. 27 
Discussion
In this study, we demonstrate that consumption of a high fat diet by female MMTV-TGF-a mice influenced mammary tumorigenesis in a reverse relationship to its effect on body weight, that is, the heaviest, obesity-prone, mice exhibited a significantly shorter latency for MT detection compared to other groups consuming the high fat diet, as well as compared to those consuming low fat chow. Furthermore, obesity-resistant mice with body weights in the range of chow-fed mice had a shortened tumor latency compared to the later group. These results using this transgenic mouse model are in general agreement with earlier studies for spontaneous and carcinogen-induced MTs, suggesting that consumption of high fat diets shorten MT latency. 26, [28] [29] [30] [31] Furthermore, we report no effects of either a high fat vs a low fat diet or body weight classification on total MT incidence, although palpable MTs were less frequently detected in the chow-fed mice. This finding of no effect on MT incidence by a high fat diet is in agreement with some, 26, 28, 29 but not all earlier studies. 31 As incidence rates are affected by the length of the experiment, if latency is altered it is possible that 'apparent' incidence rates would be dependent on the time point at which the study is completed. Since rodent experiments are usually terminated at specific ages due to predetermined experimental design or because one (or more groups) reaches a high MT incidence necessitating euthanasia, incidence rates may or may not be different among groups.
These results for transgenic MMTV-TGF-a mice are consistent with reports that higher body weight and/or obesity affects spontaneous and chemically induced MT development in rodents. [32] [33] [34] [35] [36] [37] Obesity also is a risk factor for postmenopausal breast cancer development in human beings. [38] [39] [40] [41] [42] [43] Interestingly, a recent study indicates that body fat might be a better determinant of postmenopausal breast cancer risk than obesity, as reflected by either body weight or body mass index calculation. 44 This would be consistent with our results for the high fat diet mice that demonstrate higher fat pad weights are associated with shortened MT latency regardless of body weight status. Serum factors associated with higher body weight, such as elevated estrogen, insulin and/or IGF-I levels, have been considered as mediators of the effect of obesity on postmenopausal breast cancer risk. 45 Recently, interest has focused on leptin as a possible growth factor for mammary tumorigenesis. Leptin receptors are expressed in human breast tumors and breast cancer cell lines and the addition of leptin increases cell proliferation. 46 determine serum leptin levels in the present study, it has been reported that serum leptin levels were highest in obesity-prone rats compared to obesity-resistant and control rats, while obesity-resistant rats had higher leptin levels than the control rats. 49 In a second study, comparing only high fat fed animals, obesity-prone rats had higher plasma leptin than did obesity-resistant rats. 50 In future studies, we plan to determine the relation of serum leptin to MT development. At the time this study was initiated, we chose to use the condensed milk diet because no long-term studies in mice had been published demonstrating whether mice responded to high fat diets with respect to identification of obesityprone and obesity-resistant groups. In future studies use of purified diets will further clarify and strengthen the results obtained particularly when comparing mice of the same body weight fed different fat levels. However, the fact that we demonstrate a graded effect on tumor latency and body weight in MMTV-TGF-a mice, which were fed the same diet, provides new and interesting data in the study of mammary tumorigenesis. The implication of these findings for human breast cancer is that heavier and/or fatter women would be more likely to develop breast cancer at younger ages. This would probably affect their lives to a greater degree than if tumor detection and/or breast cancer diagnosis were made at a later age or not at all because of death due to another cause.
In conclusion, these results indicate that a high fat diet has significant effects on body weight and weight gain in female C57BL6 mice. We also demonstrate that female mice overexpressing the oncogene, TGF-a, exhibit MT latency that is inversely related to their body weight when they consume a moderately high fat diet. Of further note, despite the fact that obesity-resistant and chow-fed mice have similar body weights, fat pads of obesity-resistant mice are three times heavier than those of chow-fed mice, and obesity-resistant mice have shortened MT latency. Integration of these findings suggests that increased body fat may be a mediating factor of the effect of a high fat diet on MT development. Variable effects of a high fat diet on body weight and body fat levels, even when body weight is within the normal range, may explain the lack of consistent results in studies trying to evaluate the role of high fat diet consumption as a risk factor for breast cancer. Future studies to better understand the complex relationships among these factors and mammary tumorigenesis are clearly warranted.
